TM4SF5 and liver cancer: In addition to TM4SF5-positive liver tissue from patients with HCC showing obvious ALB levels (Fig. 6a), patients with liver cancer (LIHC) from TCGA datasets showed a positive correlation between TM4SF5 and hepatic ALB levels (Fig. 6b).